We have established a contract with company “BaseClear” for microbiome analysis of the collected samples (both control arm and experimental arm). Our goal is to externally validate and publish microbiome signatures that serve as prognostic factors for patients undergoing immunotherapy. https://pubmed.ncbi.nlm.nih.gov/29097494/
